Occurrence of malignant lesions in patients referred to 131I therapy due to benign thyroid diseases;Analiza wystȩpowania zmian nowotworowych w tarczycy u pacjentów kierowanych do leczenia 131I w przebiegu łagodnych chorób tego gruczołu

Endokrynologia Polska

Volumn 57, Issue SUPPL.A, 2006, Pages

  Listewnik, Maria H ^a   Birkenfeld, Bozena ^a   Chosia, Maria ^a   Elbl, Bogumiła ^a   Zaborek, Barbara ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

131I; Goiter nodular; Graves' disease; Hyperthyroidism; Thyroid neoplasm

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERTHYROIDISM; MALE; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; THYROID GLAND; THYROID TUMOR;

ADULT; AGED; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS;

EID: 84857412681     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gietka-Czernel M, Jastrzȩbska H. Rozpoznawanie i leczenie chorób tarczycy. Ośrodek Informacji Naukowej Polfa" Warszawa 2002.
2. Sahin M, Guvener ND, Ozer F i wsp. Thyroid cancer in hyperthyroidism: Incidence rates and valus of ultrasound-guided fine-needle aspiration biopsy in this patient group. J Encorinol Invest 2005; 28: 815-818.
3. Chao TC, Lin JD, Jeng LB. Thyroid cancer with concurrent hyperthyroidism. Arch Surg 1999; 134: 130-134.
4. Jastrzȩbska H, Gietka-Czernel M, Zgliczyński S. Standardy leczenia radiojodem łagodnych chorób tarczycy. Endokr Pol 2003; 54: 187-194.
5. Centeno BA, Szyfelbein WM, Daniels GH i wsp. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine: morphologic findings and potential pitfalls. Acta Cytol 1996; 40: 1189-1197.
6. Franklyn J, Maisonneuve P, Sheppard M. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999; 353: 2111-2115.
7. Ron E, Doody MM, Becker DV. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998; 280: 347-355.
8. Cooper DS. Radioiodine for Hyperthyroidism. Where do we stand after 50 years? JAMA 1998; 280: 375-376.
9. Angusti T, Codegone A, Pelletrino R. Thyroid Cancer Prevalence after radioiodine treatment of hyperthyroidism. J Nucl Med 2000; 41: 1006-1009.
10. Dickman PW, Holm LE, Lundell G. Thyroid cancer risk after thyroid examination with 131I: A population-based cohort study in Sweden. Int J Cancer 2003; 106: 580-587.
11. Habra MA, Hijazi R, Verstovsek G. Medullary thyroid carcinoma associated with hyperthyroidism: A case report and review of the literature. Thyroid 2004; 14: 391-396.
12. Alagol F, Tanakol R, Boztepe H i wsp. Anaplastic thyroid cancer with transient thyrotixicosis: case report and literature review. Thyroid 1999; 9: 1029-1032.
13. Appetecchia M, Ducci M. Hyperfuctioning differentiated thyroid carcinoma. J Endocrinol Invest 1998; 21: 189-192.
14. Bolko P, Ła̧cka K, Matuszewska E i wsp. Czy nadczynność tarczycy czȩsto wystȩpuje u chorych ze zróżnicowanym rakiem tarczycy? Pol Arch Med Wew 2002; 57: 555-559.
15. Lin CH, Chiang FY, Wang LF. Prevalence of Thyroid cancer in hyperthyroidism treated by surgery. Kaohsiung J Med Sci 2003; 19: 379-384.
16. Kim WB, Han MS, Kim TY. Ultrasonographic screening for detection of thyroid cancer with Graves disease. Clin Endocrinol 2004; 60: 719-725.